+152.4%
MRNA vs TRMB
+19.8%
+132.6%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | TRMB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | -3.6% | +4.9% | +3.4% |
| 7D | -13.8% | -6.9% | -7.0% | -10.1% |
| 30D | -17.7% | -16.3% | -1.4% | -11.9% |
| 3M | +14.3% | -12.3% | +26.6% | +17.0% |
| 6M | +336.0% | -4.7% | +340.7% | +325.6% |
| YTD | +575.9% | -33.6% | +609.6% | +715.7% |
| 1Y | +724.4% | -31.4% | +755.7% | +874.8% |
| All | +152.4% | +19.8% | +132.6% | +80.3% |
Cumulative growth
Daily Returns
Daily percentage return beside TRMB.
Daily Out/Under-Performance
Portfolio return minus TRMB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × TRMB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded TRMB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling